ITGAX and neoplasm: β-glucan did not alter the percentages of tumor infiltrating CD3+ T lymphocytes (live CD45+CD3+NK1.1-), CD4+ T cells (live CD45+CD3+NK1.1-CD4+), cytotoxic CD8+ T cells (live CD45+CD3+NK1.1-CD8+), natural killer cells (live CD45+CD3-NK1.1+), neutrophils (live CD45+CD11c-CD11b+Ly6G+Ly6C-), or monocytes/macrophages (live CD45+CD11c-CD11b+Ly6G-Ly6C+) (Figure 6B).